Business Wire

PA-BOOMI

22.2.2024 17:18:30 CET | Business Wire | Press release

Share
Boomi Celebrates Being Positioned Highest for Ability to Execute in the Gartner® Magic Quadrant™ for Integration Platform as a Service

BoomiTM, the intelligent integration and automation leader, today announced that Gartner has positioned Boomi as a Leader and placed the company highest for Ability to Execute in its Magic Quadrant for Integration Platform as a Service (iPaaS). This will be the tenth consecutive time Boomi has been named a Leader in the Gartner Magic Quadrant for iPaaS. Gartner evaluated 17 iPaaS providers on their Ability to Execute and Completeness of Vision.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240221163767/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Boomi Celebrates Being Positioned Highest for Ability to Execute in the Gartner® Magic Quadrant™ for Integration Platform as a Service (Graphic: Business Wire)

“We believe that being positioned highest for Ability to Execute and recognized as a 10x Leader in the Gartner Magic Quadrant for iPaaS underscores our unrelenting product excellence, innovation, and execution as a team,” said Steve Lucas, CEO at Boomi. “We are pushing the envelope further than ever before to bring groundbreaking innovations to market for the benefit of our customers and partners worldwide, and it is gratifying to see the industry take note of our considerable achievements.”

Trusted by more than 20,000 customers across all industries globally for its speed, ease-of-use, and lower total cost of ownership, the cloud-native, unified, low code, scalable, open, secure, and intelligent Boomi platform helps organizations quickly and easily accelerate business outcomes.

Boomi recently announced significant updates to its platform and business, including:

Product Innovation

  • Event Streams – Available through Boomi and in AWS Marketplace, the multi-tenant enterprise message queuing and streaming service allows organizations to create integrations that are more resilient, scalable, and real-time than traditional point-to-point integration processes.
  • Boomi AI – Leveraging deidentified metadata, patterns, and best practices from 200 million integrations made with the Boomi platform, Boomi AI offers a simplified user experience that harnesses generative AI to connect and integrate applications, data, processes, people, and things across organizations.
  • Boomi GPT – The first offering available in the Boomi AI suite, Boomi GPT brings a simple, conversational experience to the Boomi platform. With Boomi GPT, organizations can harness the power of generative AI to integrate and automate faster than ever before, further democratizing innovation and accelerating business outcomes.
  • AI Patents – This year Boomi achieved two new technology patents in the field of AI that challenge the existing paradigms inherent when constructing integration processes. These patents provide additional testament to the company’s innovation leadership and dedication of its talented team of engineers, scientists, and innovators.
  • New ISO Certifications – Boomi’s ISO 27001 and 27701 certifications demonstrate the company’s continued commitment to information security and privacy compliance. As one of the only iPaaS vendors that is also FedRAMP Authorized, Boomi is consistently evolving to ensure its compliance security and privacy programs continue to meet the stringent regulatory standards set by governments and its more than 20,000 worldwide customers.
  • StateRAMP Authorization – Achieving StateRAMP Authorization reflects Boomi’s unwavering commitment to data security and compliance, and to delivering a secure and reliable solution that government agencies can rely on to safeguard their data and operations.

Business Growth

As a category-leading, global software as a service (SaaS) company, Boomi touts a growing community of more than 100,000 members, and one of the largest arrays of global systems integrators (GSIs) in the iPaaS space. The company boasts a worldwide network of approximately 800 partners, and works with the largest hyperscaler cloud service providers.

Boomi has won numerous awards for product innovation and being an employer of choice, including being named to the 2024 list of Best Places to Work by Built In and the CRN Cloud 100 list for innovation in cloud-based technology development. In addition, Boomi has received the prestigious 5-star rating in the CRN Partner Program Guide for two consecutive years, was named a Fire Award honoree for innovation by the Philadelphia Business Journal and a Gold Stevie® Award winner in the American Business Awards for Company of the Year in 2023. Boomi has also been recognized by The Software Report as a Top 100 Software Company and for having one of the Top 50 SaaS CEOs.

To learn more, read the Gartner report: “Magic Quadrant for Integration Platform as a Service.”

Additional Resources

Gartner Disclaimer:

Gartner, Magic Quadrant for Integration Platform as a Service, Keith Guttridge, Andrew Comes, Shrey Pasricha, Max van den Berk, Andrew Humphreys, February 19, 2024

Boomi was recognized as Dell Boomi in 2014-2019. The report was previously titled as Magic Quadrant for Enterprise Integration Platform as a Service from 2017-2021 and in 2014. The report was titled as Magic Quadrant for Enterprise Integration Platform as a Service, Worldwide in 2015 & 2016 and as Magic Quadrant for Integration Platform as a Service, Worldwide in 2023.

Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. GARTNER is a registered trademark and service mark of Gartner and Magic Quadrant is a registered trademark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved. Note: Boomi was recognized as Dell Boomi from 2014 to 2019.

About Boomi

Boomi powers the future of business with intelligent integration and automation. As a category-leading, global software as a service (SaaS) company, Boomi celebrates more than 20,000 global customers and a worldwide network of 800 partners. Organizations turn to Boomi’s award-winning platform to connect their applications, data, and people to accelerate digital transformation. For more information, visit boomi.com.

© 2024 Boomi, LP. Boomi, the ‘B’ logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240221163767/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease1.5.2026 23:28:00 CEST | Press release

Jakafi XR is a once-daily, film-coated, extended-release formulation of Jakafi®(ruxolitinib)Once-daily Jakafi XR was shown to provide consistent, day-long exposure comparable to twice-daily JakafiJakafi XR will be available for pharmacy orders by May 8 Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) extended-release tablets for the treatment of adults with intermediate- or high-risk myelofibrosis (MF); adults with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea; as well as adults and children aged 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD after failure of one or two lines of systemic therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260501334677/en/ “The approval of Jakafi XR reinforces Incyte’s leadership in hematology and our focus on meetin

Barilla Hosts Surprise Formula 1® Family Reunion Dinner During Miami Race Weekend1.5.2026 18:08:00 CEST | Press release

Drivers and team members of Formula 1® were reunited with their loved ones during a night that also celebrated the new partnership between Barilla and the Visa Cash App Racing Bulls Formula 1® Team. A special invitation, a table, and a plate of pasta shared by people who are often apart. That’s all it took for Barilla to bring the spirit of togetherness to Miami during the opening day of the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430832316/en/ Barilla hosts Arvid Lindblad, Mikaela Shiffrin, and Nico Rosberg with Chef Massimo Bottura at Torno Subito, where the Formula 1® community came together for a surprise dinner. Barilla, the Official Pasta Partner of Formula 1®, welcomed team members and their families to Torno Subito Miami, the restaurant by three-Michelin-starred Chef Massimo Bottura, with the kitchen led by Chef Bernardo Paladini, for an evening where engines wer

TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 12:07:00 CEST | Press release

Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the

Andersen Consulting styrker sine kompetencer inden for digital transformation med Weexa1.5.2026 10:07:00 CEST | Pressemeddelelse

Andersen Consulting indgår en samarbejdsaftale med Weexa, en global leverandør af løsninger inden for digital transformation, B2B-integration og digitalisering af forsyningskæden. Med hovedsæde i Frankrig leverer Weexa end-to-end-tjenester, der hjælper organisationer med at optimere, sikre og skalere deres digitale økosystemer. Virksomheden specialiserer sig i styring af B2B-datastrømme og digitalisering, hvilket muliggør problemfri kommunikation mellem applikationer både internt og på tværs af organisationer gennem teknologier som EDI, API'er og e-fakturering. Weexa tilbyder også SAP-integration og supply chain-løsninger til styring af lager og transport, sideløbende med strategisk rådgivning, projektlevering og vedligeholdelse af tredjepartsapplikationer. Weexa betjener organisationer inden for fødevaresektoren, detailhandel, engros, logistik, transport, bilindustrien, sundheds- og mediesektoren og hjælper globale virksomheder med at optimere deres ydeevne samt at overholde de nyeste

Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 01:17:00 CEST | Press release

Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye